Opiant Pharmaceuticals
(NASDAQ) OPNT
Opiant Pharmaceuticals Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$191.43M
Net Income (TTM)
$33.49M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
OPNT News
OPNT: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Opiant Pharmaceuticals
Industry
Pharmaceuticals
Sector
Health CareEmployees
37
CEO
Roger Crystal, MD, MBA
Website
www.opiant.comHeadquarters
Santa Monica, CA 90401, US
OPNT Financials
Key Financial Metrics (TTM)
Gross Margin
78%
Operating Margin
13%
Net Income Margin
7%
Return on Equity
7%
Return on Capital
8%
Return on Assets
4%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$31.66M
Operating Income
$5.16M
EBITDA
$5.83M
Operating Cash Flow
$1.93M
Capital Expenditure
$0.00
Free Cash Flow
$1.93M
Cash & ST Invst.
$52.87M
Total Debt
$17.08M
Opiant Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonCurrently no data to display.
Quarterly Performance
Revenue
$173.87M
+1138.3%
Gross Profit
$173.87M
+1483.3%
Gross Margin
100.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
37
N/A
Net Income
$9.92M
-390.2%
EBITDA
$9.46M
-337.6%
Quarterly Fundamentals
Net Cash
$18.86M
-38.0%
Accounts Receivable
$41.11K
-99.7%
Inventory
$0.00
N/A
Long Term Debt
$14.41M
-26.6%
Short Term Debt
$2.11M
+633.4%
Return on Assets
4.27%
N/A
Return on Invested Capital
8.11%
N/A
Free Cash Flow
$5.15M
-1898.7%
Operating Cash Flow
$4.74M
-1755.2%